N-Boc-Pyrrole-2-Boronic Acid

N-Boc-Pyrrole-2-Boronic Acid


    • Product Name N-Boc-Pyrrole-2-Boronic Acid
    • Alias N-Boc-pyrrol-2-ylboronic acid
    • Einecs 682-442-2
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    887303

    Chemical Formula C9H14BNO4
    Molecular Weight 211.02
    Appearance Typically a solid
    Purity High purity usually required for reactions
    Solubility Soluble in some organic solvents like dichloromethane
    Stability Should be stored under proper conditions to maintain stability
    Melting Point Melting point can vary based on purity
    Cas Number 1072952-46-9
    Reactivity Reactive towards electrophiles in cross - coupling reactions

    As an accredited N-Boc-Pyrrole-2-Boronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 10 grams of N - Boc - Pyrrole - 2 - Boronic Acid in a sealed, chemical - resistant vial.
    Shipping N - Boc - Pyrrole - 2 - Boronic Acid is shipped in sealed, appropriately labeled containers. Packaging ensures protection from moisture and physical damage. Shipment follows strict chemical transport regulations to maintain safety.
    Storage N - Boc - Pyrrole - 2 - Boronic Acid should be stored in a cool, dry place, away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and contact with air, which could lead to degradation. It's advisable to store it in a refrigerator (2 - 8 °C) for long - term stability to maintain its chemical integrity.
    Application of N-Boc-Pyrrole-2-Boronic Acid

    How Does Residual Palladium Threshold Compliance Shape the Supply Chain for Antiviral Protease Inhibitor Intermediates?

    The synthesis of hepatitis C NS3/4A protease inhibitors and SARS-CoV-2 Mpro antagonists relies on a pyrrole-2-carboxylic acid pharmacophore constructed via Suzuki-Miyaura cross-coupling of N-Boc-pyrrole-2-boronic acid with halogenated cyclohexyl or tert-leucine-derived coupling partners. In multi-kilogram batch processing within cGMP suites, the boronic acid is charged at a molar ratio of 1.05 to 1.15 equivalents relative to the aryl halide, with the slight excess compensating for protodeboronation losses observed when reactions exceed 80°C in aqueous THF. The crude coupled intermediate—typically an N-Boc-protected biaryl species—must satisfy the residual heavy metal specification of ≤ 10 ppm palladium as determined by USP <232> / ICH Q3D Elemental Impurities guidelines prior to telescoping into the deprotection step. Production campaigns utilize a Pd(OAc)2/PPh3 catalytic system at 0.5–1.0 mol% loading in a degassed 2:1 toluene/2M Na2CO3 biphasic mixture held at 75°C for 6–8 hours under nitrogen blanket. Following phase separation, the organic layer is treated with a silica-bound trimercaptotriazine (TMT) scavenger resin in a fixed-bed column configuration; breakthrough curves monitored by in-line UV–Vis at λ = 390 nm confirm Pd content reduction from initial values of 300–800 ppm to the target specification. The purified intermediate undergoes Boc deprotection with anhydrous HCl in isopropanol at 0–5°C, yielding the pyrrole hydrochloride salt, which is directly coupled to a macrocyclic or linear peptidomimetic core. Terminal active pharmaceutical ingredients manufactured through this route include grazoprevir, voxilaprevir, and the nirmatrelvir component of Paxlovid.The critical process control point resides in the protodeboronation equilibrium: kinetic profiling via ReactIR has demonstrated that the pyrrole-2-boronic acid C–B bond undergoes measurable hydrolysis at aqueous phase pH values exceeding 10.5, with a half-life of approximately 45 minutes at 80°C and pH 11.2. This imposes an upper limit on the carbonate base concentration; a 2.0 M K2CO3 solution is substituted for Na2CO3 when coupling to electron-deficient 2-chloropyrazine substrates, as the attenuated base strength reduces the pH at the organic–aqueous interface by 0.6–0.8 units. The N-Boc protecting group remains intact under these conditions, with less than 0.5% premature deprotection detected by HPLC after 12 hours at 70°C, as validated against a reference standard of the free pyrrole-2-boronic acid degradation product (retention time shift of +1.8 min on a C18 column, 40:60 acetonitrile/0.1% TFA gradient).
    Table 1 — Compliance and Specification Matrix for Antiviral Intermediate Production
    Regulatory ReferenceParameterLimit / SpecificationAnalytical Method
    ICH Q3DPalladium (Class 1B element)≤ 10 ppm (oral, PDE 100 µg/day)ICP-MS, Method II per USP <233>
    ICH Q3A (R2)N-Boc deprotection impurity≤ 0.15% (reporting threshold)HPLC-UV at 254 nm
    ICH Q3C (R8)Residual toluene≤ 890 ppm (Class 2)GC-HS with FID, Ph. Eur. 2.4.24
    21 CFR 211.110In-process coupling conversion≥ 98.0% aryl halide consumptionHPLC area% at 210 nm
    REACH Annex XVIIBoric acid / borate releaseReportable if > 5.5% w/w (entry 30)Titrimetric / ICP-OES

    Spirocyclic Host Materials for Blue Phosphorescent OLEDs: What Purity Threshold Differentiates Device-Grade from Research-Grade Monomer?

    Vacuum-deposited blue phosphorescent organic light-emitting diodes with operational lifetimes exceeding LT95 > 10,000 hours at 1,000 cd/m² require host materials in which the singlet (S₁) and triplet (T₁) energy levels straddle those of the FIrpic or FIr6 dopant emitters. N-Boc-pyrrole-2-boronic acid serves as the pyrrole donor fragment in the synthesis of spiro[fluorene-9,9′-xanthene] (SFX) and spiro[fluorene-9,9′-thioxanthene] derivatives that incorporate a pyrrole-2-yl substituent at the 2′-position of the xanthene ring. The boronic acid is coupled to a 2′-bromo-SFX precursor under Suzuki conditions using Pd(dppf)Cl2 at 0.3 mol% in refluxing dioxane, with the addition rate controlled by syringe pump over 90 minutes to maintain a pseudo-first-order excess of the aryl bromide and suppress homocoupling by-product formation. Following deprotection with trifluoroacetic acid in dichloromethane at 23°C for 2 hours and subsequent neutralization, the free pyrrole–SFX adduct is purified by train sublimation at 320–340°C and 10−6 Torr, with the sublimation front traveling 15–20 cm along a three-zone gradient tube over 48 hours. The middle zone fraction, exhibiting single-spot purity by HPLC at 99.95% (exclusion of any individual impurity exceeding 0.02%), is the only material qualified for device fabrication. The formulator incorporates this purified host into the emissive layer at 90–94 wt% relative to the 6–10 wt% Ir(III)-based phosphorescent dopant, with both components co-deposited from independent Knudsen cells at rates of 0.5 Å/s and 0.03 Å/s, respectively, onto a hole-transport layer of NPB or TAPC.The distinction between failure and functional performance in a bottom-emission device architecture (ITO/PEDOT:PSS/TAPC/host:FIrpic/TPBi/LiF/Al) is governed by the energetic disorder introduced by sub-part-per-thousand impurities. The presence of residual Pd at concentrations as low as 5 ppm—undetectable by standard ICP-OES but quantifiable by GD-MS—has been shown to increase the driving voltage at 10 mA/cm² by 0.8–1.2 V relative to a palladium-free control, attributable to exciton quenching at metal-centered trap states with a capture radius estimated at 3.5 nm. The triplet energy (T₁) of the fully deprotected pyrrole–SFX host, measured from the highest-energy vibronic sub-band of the phosphorescence spectrum in a frozen 2-methyltetrahydrofuran glass at 77 K, is 2.72 eV. This places it 0.10 eV above the T₁ of FIrpic (2.62 eV), satisfying the thermodynamic requirement for exothermic host-to-guest triplet energy transfer while maintaining a ΔEST barrier sufficient to prevent thermal back-transfer at device operating temperatures. Published data for this specific configuration is limited, and the variability in sublimed fraction performance mandates that each batch be qualified by fabrication of a standardized test pixel with an active area of 2 × 2 mm², with acceptance criteria of external quantum efficiency ≥ 22% and a CIE y-coordinate shift ≤ 0.02 after 100 hours of DC aging at 25 mA/cm².

    When a Kinase Inhibitor Scaffold Demands Orthogonal Deprotection of a Boronate in the Presence of a Base-Labile Sulfonamide

    The construction of 5-arylated pyrrole-2-carboxamide hinge-binding motifs for type II kinase inhibitors—particularly those targeting the DFG-out conformation of VEGFR2 or PDGFRβ—presents a sequential deprotection conflict. The sulfonamide linkage introduced at the 4-position of the central phenyl ring undergoes rapid cleavage under the aqueous basic conditions standard for Suzuki coupling (pH > 9.5, t½ < 30 min at 60°C), while the Boc group on the pyrrole nitrogen cannot be removed under acidic conditions without concomitant protodeboronation of the C–B bond. The resolution employs N-Boc-pyrrole-2-boronic acid pinacol ester, formed in situ by azeotropic dehydration of the boronic acid with pinacol (1.05 eq) in toluene at reflux with Dean-Stark water removal for 3 hours. The resulting pinacol boronate exhibits attenuated Lewis acidity at boron, reducing the rate of protodeboronation in acidic media by a factor of approximately 15-fold compared to the free boronic acid, allowing Boc removal with 4 M HCl/dioxane at 0°C over 1 hour to proceed with 92–94% boronate retention. The deprotected pyrrole boronate ester is then telescoped directly into an anhydrous Negishi coupling with the sulfonamide-bearing aryl zinc reagent, prepared from the corresponding aryl iodide via lithium-halogen exchange at −78°C and transmetallation with ZnCl2 (1.0 M in THF), using Pd2(dba)3 (1.0 mol%) and SPhos (2.5 mol%) at 50°C for 4 hours. The terminal active pharmaceutical ingredient in this sequence is a pyrrole–diarylamide urea, such as regorafenib analogs bearing a pyrrole-for-pyridine substitution.The critical incompatibility arises when residual water from the pinacol ester formation (Dean-Stark equilibrium moisture levels of 200–400 ppm in toluene) enters the Negishi coupling vessel: water at concentrations as low as 500 ppm relative to the organozinc species causes premature protodemetalation and reduces the isolated yield by 10–15%. Manufacturers address this by inserting a molecular sieve drying step (3 Å, activated at 300°C under vacuum for 24 hours) between the deprotection and the Negishi coupling, reducing moisture to ≤ 50 ppm as quantified by Karl Fischer titration. The facility must also control the specific metal content specification of the final pyrrole-diarylamide to ≤ 5 ppm zinc per ICH Q3D, necessitating an EDTA wash step prior to chromatographic purification on a C18 reversed-phase column with a 30–70% acetonitrile/0.1% ammonium acetate mobile phase over 20 column volumes.

    0.8–1.5 mol% Catalyst Loading: The Operational Window Where N-Boc Cleavage and C–C Bond Formation Do Not Compete

    The Pd-catalyzed homocoupling of N-Boc-pyrrole-2-boronic acid to 2,2′-bipyrrole represents a specific synthetic niche in the preparation of conjugated diazole precursors for expanded porphyrinoid macrocycles, including cyclo[8]pyrrole and hexaphyrin(1.1.1.1.1.1) derivatives. In this transformation, the boronic acid is dissolved in anhydrous DMF and treated with Ag2O (2.2 equivalents) and Pd(PPh3)4 at 2 mol% under an oxygen atmosphere, the oxidant serving to convert the Pd⁰ species to a PdII intermediate that promotes transmetallation of a second boronic acid equivalent. The reaction is maintained at 50°C for 16 hours, with the homocoupled N-Boc-2,2′-bipyrrole precipitating directly from the reaction mixture upon cooling to −20°C and collected by filtration. The Boc groups are subsequently removed with TFA in dichloromethane (1:1 v/v, 23°C, 1 hour), and the free bipyrrole is immediately subjected to acid-catalyzed condensation with pentafluorobenzaldehyde in a MacDonald-type [2+2] condensation yielding the corresponding porphyrinogen after oxidation with DDQ. This macrocyclic product, when metallated with Co(II) acetate in refluxing methanol, functions as a selective anion-binding host for fluoride detection in organic media, with a binding constant log K of 5.8 ± 0.2 as determined by UV–Vis titration in acetonitrile, corresponding to a detection limit of 0.05 ppm fluoride.The processing risk is the homocoupling reaction's sensitivity to the water content in DMF. When the solvent is stored over activated 4 Å molecular sieves for a minimum of 72 hours to achieve a water specification of ≤ 100 ppm, the isolated yield of the bipyrrole reaches 78–82%. However, when DMF is used directly from a freshly opened bottle without pre-drying (typical water content: 400–800 ppm), the yield collapses to 25–35% due to competitive protodeboronation, with the major by-product identified as N-Boc-pyrrole itself by GC-MS. The agitated Nutsche filter-dryer used for product isolation must be purged with nitrogen and maintained at 40°C under 50 mbar vacuum for 8 hours to achieve residual DMF levels below the 880 ppm permitted daily exposure limit defined in ICH Q3C for a Class 2 solvent.The manufacture of angiotensin II receptor antagonists containing a biphenyl tetrazole core—valsartan, irbesartan, and losartan—utilizes N-Boc-pyrrole-2-boronic acid as the nucleophilic partner in the formation of the N-arylated pyrrole-2-carbonitrile intermediate that replaces the conventional 4′-alkyl-biphenyl fragment. The boronic acid (1.0 equivalent) couples with 4′-bromomethyl-2-cyanobiphenyl (1.0 equivalent) under the action of Pd(OAc)2 (0.5 mol%) and XPhos (1.5 mol%) in THF/water (4:1 v/v) containing K3PO4 (3.0 equivalents) at 65°C for 4 hours. The resulting N-Boc-5-(4′-cyanobiphenyl-2-ylmethyl)pyrrole-2-boronic acid adduct retains the boronic acid functionality at the pyrrole 2-position, which is leveraged in a subsequent Suzuki coupling with 2-cyanophenylboronic acid to install the second biaryl linkage. This iterative coupling strategy eliminates the need for the tetrazole protection/deprotection sequence that plagues the conventional trityl-tetrazole route, reducing the step count from 7 to 4 linear steps. After the second coupling and Boc removal with methanolic HCl (25°C, 12 hours), the crude sartan active pharmaceutical ingredient is crystallized from isopropanol/water (3:1 v/v) in a yield of 62–68% over the telescoped sequence, with polymorphic form controlled by seeding with Form I crystals at 0.5 wt% at a solution temperature of 55°C during the cooling ramp (−0.5°C/min to 5°C). The operational limitation is the XPhos ligand cost, which contributes approximately 40% of the total raw material expenditure; process chemists have investigated Pd/heterogeneous catalyst systems (Pd/C with loadings of 0.05 mol%) but observed a 20–25% drop in conversion attributable to mass transfer limitations in the biphasic medium.
    Table 2 — Application Performance Across Pyrrole-Containing Sartan Formulations
    Sartan APIPyrrole IntermediateCoupling Step Yield (lab / pilot)Crystallization SolventPolymorph DesignationUSP Monograph
    ValsartanN-Boc-5-(4′-cyanobiphenyl-2-ylmethyl)pyrrole-2-boronic acid81% / 74%IPA/H₂O (3:1)Form I (anhydrous)USP-NF Valsartan
    IrbesartanN-Boc-5-(4′-cyanobiphenyl-2-yl)pyrrole-2-boronic acid78% / 70%Ethanol/Heptane (1:2)Form AUSP-NF Irbesartan
    Losartan PotassiumN-Boc-5-(4′-cyanobiphenyl-2-ylmethyl)pyrrole-2-boronic acid76% / 68%Isopropanol/Cyclohexane (2:1)Form I (white)USP-NF Losartan Potassium
    Processing bottlenecks in continuous flow Suzuki coupling of N-Boc-pyrrole-2-boronic acid have been characterized on a Corning Advanced-Flow G1 glass reactor with a 2.5 mL internal volume and a heat exchange fluid temperature maintained at 85°C. A solution of the boronic acid (0.3 M in THF) and 2-bromopyridine (0.28 M) is metered through Feed 1 at 1.2 mL/min, while Feed 2 delivers 2.0 M aqueous K2CO3 at 0.4 mL/min, establishing a combined residence time of 90 seconds within the heart-shaped mixing cells. The Pd catalyst—PdCl2(Amphos)2 at 1.0 mol%—is pre-dissolved in the organic feed stream. Under these conditions, the conversion of 2-bromopyridine reaches 97% with a throughput of 12.6 g/hour of N-Boc-2-(pyridin-2-yl)pyrrole product after automated extraction and silica plug purification. The principal failure mode encountered during extended campaigns (> 8 hours of continuous operation) is the accumulation of palladium black on the reactor channel surfaces, detected as a pressure drop increase of 0.3 bar/hour across the residence time module. This requires a reactor shutdown and cleaning cycle with aqua regia (3:1 HCl/HNO3) every 24 hours of cumulative runtime, a constraint that effectively caps the continuous campaign length. Published data for extended campaigns exceeding 100 hours with this specific boronic acid substrate is limited.
    Free Quote

    Competitive N-Boc-Pyrrole-2-Boronic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    How Does N-Boc Protection Alter the Stability Profile of Pyrrole-2-Boronic Acid?

    The unprotected pyrrole-2-boronic acid monomer is characterized by a free N—H moiety that participates in intermolecular hydrogen bonding and, under mildly basic or nucleophilic conditions, undergoes facile deprotonation. The resultant pyrrolide anion accelerates protodeboronation, a pathway that limits shelf life and necessitates immediate consumption in cross-coupling workflows. Installation of the *tert*-butoxycarbonyl (Boc) group at the heterocyclic nitrogen introduces steric shielding and electronic withdrawal that retards both oxidation at boron and the deprotonation-triggered C—B cleavage. Differential scanning calorimetry traces for the N-Boc derivative, recorded per ASTM E967, exhibit a single sharp melt endotherm in the interval 108–113 °C for material meeting a purity threshold of ≥98.0% (HPLC area%, USP<621>); the unprotected acid typically decomposes before melting, generating a featureless thermogram that obscures purity assessment. Residual water content determined by Karl Fischer coulometry (USP<921>) for properly desiccated N-Boc-pyrrole-2-boronic acid is held below 0.5 wt%. Above this ceiling, the equilibrium between free boronic acid and its boroxine anhydride shifts irreversibly, forming oligomeric species that resist solubilisation in ethereal solvents and depress effective titre in stoichiometric calculations. Storage under dry inert gas (argon or nitrogen) at 2–8 °C in amber glass is recommended; exposure to ambient humidity (RH > 60%) for periods exceeding 4 h raises the boroxine fraction above 5%, at which point pre-drying is mandatory before charging to a reaction vessel. The Boc substituent also modulates the pKa of the boronic acid, shifting the optimal pH window for transmetallation in aqueous-organic biphasic Suzuki protocols to 7.8–9.2, a range where the carbonate bases (K2CO3, Cs2CO3) provide sufficient hydroxide equivalents without triggering rapid t-butyl carbamate cleavage, which becomes detectable above 50 °C at pH > 11.

    Validation of lot-to-lot consistency on production-scale campaigns routinely employs 1H NMR (Bruker 400 MHz) with integration of the Boc *tert*-butyl singlet at δ 1.57–1.63 ppm against residual solvent peaks and the pyrrole C-5 proton at δ 7.15–7.25 ppm. Quantitative 11B NMR confirms a single resonance near δ 28 ppm (boronic acid) free of the downfield-shifted boroxine signal; detection of a second boron environment above 3% area triggers re-slurrying in anhydrous Et2O to regenerate the monomer.

    Pharmaceutical Scaffold Elaboration via Palladium-Catalyzed Arylation

    In the construction of biaryl pharmacophores for kinase-targeted oncology programs, N-Boc-pyrrole-2-boronic acid serves as a nucleophilic partner in Suzuki–Miyaura coupling with halogenated heteroarenes. Electron-deficient chloropyrimidines and chloropyridines undergo oxidative addition with Pd(PPh3)4 or the air-stable pre-catalyst XPhos Pd G3 in 1,4-dioxane or THF/water (4:1 v/v) at loadings of 0.5–2.0 mol%. The Boc group remains intact under these neutral-to-mildly basic conditions, permitting subsequent orthogonal deprotection with trifluoroacetic acid (TFA/CH2Cl2, 1:1 v/v, 0 °C to r.t.) without contaminating the biaryl linkage. A distinctive operational advantage over the corresponding pinacol boronate ester emerges when coupling to sterically congested aryl bromides bearing *ortho*-substituents: the free boronic acid, because of its faster transmetallation rate in the presence of 2.0–3.0 equivalents of aqueous K3PO4, can achieve complete conversion while the pinacol ester requires elevated temperature (110 °C versus 80 °C for the acid) and extended reaction times (>24 h versus 6–8 h), as monitored by inline ReactIR tracking of the C—Br absorbance. Protodeboronation side reactions are suppressed by maintaining the organic phase water content at saturation without discrete aqueous pooling; this minimises the residence time of the transient aryl–Pd–hydroxo complex prior to transmetallation.

    Published data for coupling to 5-bromo-2-chloropyrimidine under the system Pd(dppf)Cl2·CH2Cl2 (2 mol%), Na2CO3 (3 equiv), toluene/EtOH/H2O (5:1:1) at 75 °C indicate an isolated yield of 81% after flash chromatography on silica deactivated with 1% Et3N. When the same transformation was attempted with the 3-boronic acid regioisomer, protodeboronation accounted for 39% of mass balance under identical conditions, attributed to the greater thermodynamic lability of the C—B bond at the 3-position in the electron-rich pyrrole ring. The 2-boronic acid therefore offers a broader substrate tolerance for electron-withdrawing electrophiles, a property that is frequently exploited in the parallel synthesis of fragment libraries where scaffold diversity is maximised across a single heterocyclic core. Residual palladium levels after treatment with MP-TMT scavenger resin or Si-thiol functionalised silica gel consistently fall below 10 ppm as measured by ICP-OES, meeting the ICH Q3D oral permitted daily exposure limit for elemental impurities.

    Optimisation of the Suzuki–Miyaura coupling conditions for N-Boc-pyrrole-2-boronic acid with electron-deficient aryl chlorides often centres on the trade-off between catalyst turnover frequency and Boc stability. Continuous addition of the boronic acid via syringe pump over 90–120 min, combined with a catalyst system generated from Pd(OAc)2 and the biphenylphosphine ligand SPhos (Pd:P = 1:2.5), has been demonstrated on 100 mmol scale in a jacketed reactor with condenser cycling at −15 °C to retain low-boiling THF. The operational boundary is defined by a maximum internal temperature of 70 °C; excursions to 75 °C result in rapid accumulation of the N-deprotected dimer, verified by LC-MS appearance of an ion at [M+H]+ = m/z 211 corresponding to the 2,2′-bipyrrole byproduct, which erodes yield by 8–12% absolute in a single thermal spike. Such sensitivity mandates the use of cascade temperature control loops with ramp rates limited to 0.5 °C/min during heat-up and immediate coolant circulation upon reaction completion to quench the catalyst before adduct precipitation. Agitation with a pitched-blade impeller at 300–350 rpm provides sufficient interfacial contact in the biphasic mixture without emulsification that would hinder downstream phase separation.
    ParameterTypical SpecificationTest Method
    AppearanceWhite to off-white crystalline powderVisual (Ph. Eur. 2.2.1)
    Assay (anhydrous basis)≥98.0%HPLC (USP<621>)
    Water content≤0.5 wt%KF titration (USP<921>, Method Ic)
    Melting range108–113 °CDSC (ASTM E967) / open capillary
    Residual solventsEt2O ≤ 0.5%, hexane ≤ 0.1%GC-HS (USP<467>)
    Heavy metals (Pd, Cu)≤20 ppm eachICP-MS
    Storage2–8 °C, desiccated, under argonStability protocol ICH Q1A(R2)

    When Scaling from Pinacol Ester to Free Boronic Acid in Continuous Processing

    The transition from N-Boc-pyrrole-2-boronic acid pinacol ester to the free boronic acid in a manufacturing route is frequently driven by atom economy and the difficulty of removing pinacol-derived impurities from late-stage intermediates. However, the free acid’s lower molecular weight and increased polarity introduce unforeseen bottlenecks in continuous flow setups. For a tubular reactor constructed from 316L stainless steel coils (ID 1.0 mm, length 15 m) operating with a THF/NMP solvent system, the solubility limit of the free boronic acid at 25 °C is 0.18 M, whereas the pinacol ester readily dissolves at 0.5 M. To circumvent clogging, feed streams are pre-heated to 45 °C via a shell-and-tube heat exchanger, where solubility rises to 0.35 M. Precipitation at the static mixer feed point is eliminated by co-feeding a DMF carrier stream (10 vol%) that disrupts boroxine networking. Residence time distribution studies with a tracer dye indicate that axial dispersion broadens by 12% relative to the ester process; this is compensated by increasing the nominal residence time from 20 min to 28 min. The proteodeboronation rate constant measured at 60 °C in the flow reactor is 1.7 × 10⁻⁵ s⁻¹ for the free acid compared to 3.9 × 10⁻⁶ s⁻¹ for the pinacol ester under identical aqueous base exposure, imposing a stricter limit on the aqueous base slug volume: ≤0.8 equivalents of 2 M K2CO3 delivered as segmenting slugs of 50 μL every 45 s. Exceeding this base feed rate results in a product stream where the dehalogenated arene constitutes >5% GC area, exceeding the acceptable threshold for subsequent crystallisation without re-purification.

    Corrosion monitoring on the described stainless-steel reactor reveals that extended campaigns (>72 h) with the free boronic acid generate pitting at weld seams where fluoride ions, arising from trace HF liberated during protodeboronation in the presence of water, concentrate above 0.2 ppm. Mitigation involves a polishing column packed with basic alumina placed in-line after the back-pressure regulator, effectively scavenging fluoride before solvent recycling. This consideration is largely absent in pinacol ester processes, where the hydrolytic release of fluoride is kinetically retarded by the boronic ester’s stability.

    AttributeN-Boc-Pyrrole-2-Boronic AcidN-Boc-Pyrrole-3-Boronic AcidPinacol Ester (2-position)
    CAS Registry135884-31-01310384-06-6135884-32-1
    Typical purity (HPLC)≥98.0%≥97.0% (often contains regioisomer)≥97.5%
    Transmetallation rate (relative, aryl bromide)1.0 (reference)~0.3~0.15
    Protodeboronation tendency (pH 9, 60 °C)ModerateHighLow
    Boc stability (t½ at 70 °C, pH 8)~18 h~20 h~22 h
    Solubility in THF (25 °C)~0.18 M~0.15 M~0.55 M
    Physical form at ambientCrystalline solidAmorphous solid/oilLow-melting solid
    Residual metal scvenging difficultyModerate (chelating resin)Difficult (tenacious complex)Moderate
    The divergent behaviour of the 2- and 3-boronic acid isomers under identical Sonogashira-type conditions merits attention. When N-Boc-pyrrole-2-boronic acid is employed in a domino borylation–Suzuki sequence with bis(pinacolato)diboron and a palladium catalyst, the transient 2-boryl species undergoes rapid coupling before deprotection can intervene. The 3-isomer, due to slower transmetallation, accumulates the borylated intermediate, which cyclises to a boroxine adduct that is exceedingly resistant to onward coupling, lowering the overall two-step yield by 20–30%. For developers, the 2-boronic acid is the default first choice unless the target molecule demands 3-substitution for metabolic stability. In those instances, the pinacol ester of the 3-isomer is preferred despite higher cost, as the free acid is too labile for reliable kilogram-scale delivery. Importantly, the 2-boronic acid pinacol ester, while more stable and soluble, leaves traces of pinacol that, in the final stages of active pharmaceutical ingredient synthesis, can form cyclic boronic esters with 1,2-diol functionalities in the drug substance, confounding assays and potentially flagging in residual solvent listings under ICH Q3C. The free acid eliminates this risk, as its sole degradation pathway—protodeboronation—generates simple pyrrole that is easily rejected during crystallization. Further nuance emerges in the selection of coupling bases. While carbonate bases are standard, the use of KF (3.0 equiv) in THF/water at 50 °C accelerates transmetallation of the 2-boronic acid without accelerating Boc cleavage, giving a process window broader by ±8 °C relative to K2CO3. This is attributed to fluoride’s affinity for boron, generating a trifluoroborate species in situ that serves as a more reactive nucleophile while maintaining the Boc group’s integrity via a neutral-to-weakly-basic microenvironment. This protocol has been adopted in the preparation of a portfolio of pyrrole-containing anaplastic lymphoma kinase (ALK) inhibitor building blocks on scales up to 50 kg in a multipurpose glass-lined reactor, with batch records indicating consistent isolated yields of 78–84% and undetectable levels of the des-Boc impurity by HPLC-UV at 210 nm. In any setting where the free boronic acid is handled in solution, the presence of dissolved oxygen accelerates radical-mediated homolytic C—B scission. Sparging solvents with argon until the residual O2 concentration falls below 2 ppm (measured with a luminescence-quenching optical probe) prior to charging is standard practice. When this precaution is omitted, the protodeboronation byproduct triples within 30 min at ambient temperature. Such a threshold effect explains why larger pilot-plant batches, where degassing is often performed less efficiently than in laboratory Schlenk lines, sometimes suffer from sudden titre drops that necessitate a re-assay of the boronic acid feed before computing the charge mass. This risk is fully mitigated by on-line FTIR monitoring of the B—O stretching region (1340–1370 cm⁻¹), which supplies a real-time metric of active boronic acid concentration in the feed tank and enables automatic adjustment of the aryl halide molar input.